Brick & Kyle Associates’s Exact Sciences EXAS Stock Holding History

Brick & Kyle Associates’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-3,560	Closed	-$225K	–	74
2018 Q4	$225K	Buy	+3,560	New	+$244K	0.22%	80
2018 Q2	$451K	Hold	7,550	–	–	0.35%	63
2018 Q1	$304K	Sell	7,550 -200	-3%	-$9.76K	0.25%	76
2017 Q4	$407K	Sell	7,750 -250	-3%	-$13.3K	0.33%	67
2017 Q3	$377K	Hold	8,000	–	–	0.3%	69
2017 Q2	$283K	Hold	8,000	–	–	0.24%	80
2017 Q1	$189K	Hold	8,000	–	–	0.15%	97
2016 Q4	$107K	Hold	8,000	–	–	0.09%	121
2016 Q3	$149K	Hold	8,000	–	–	0.12%	101
2016 Q2	$98K	Hold	8,000	–	–	0.08%	132
2016 Q1	$54K	Hold	8,000	–	–	0.05%	170
2015 Q4	$74K	Hold	8,000	–	–	0.07%	139
2015 Q3	$144K	Hold	8,000	–	–	0.14%	102
2015 Q2	$238K	Hold	8,000	–	–	0.2%	85
2015 Q1	$176K	Hold	8,000	–	–	0.15%	98
2014 Q4	$220K	Buy	+8,000	New	+$195K	0.19%	90

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Brick & Kyle Associates's EXAS Position: Q1 2019 in Review

Brick & Kyle Associates sold out of Exact Sciences (EXAS) in Q1 2019, closing a stake of 3,560 shares — an estimated $225K sold.

Brick & Kyle Associates first reported a position in EXAS in Q4 2014 and held it in 16 quarters. The position peaked at $451K in Q2 2018. 424 funds tracked by Wall St. Rank hold EXAS as of Q1 2019.

Brick & Kyle Associates reported no remaining Exact Sciences position as of Q1 2019 after selling out during the quarter.
Brick & Kyle Associates sold 3,560 Exact Sciences shares in Q1 2019, an estimated $225K.
Brick & Kyle Associates first reported a position in Exact Sciences in Q4 2014 and held it in 16 quarters.
Brick & Kyle Associates's Exact Sciences position peaked at $451K in Q2 2018.
424 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2019.

Based on Brick & Kyle Associates's 13F filing for Q1 2019, filed 14 Jun 2019.